Hints and tips:
Related Special Reports
...These one-off drugs can cost hundreds of thousands or even millions of dollars, but transform the health of a patient and reduce healthcare costs in the longer term....
...Sultan al-Jaber is planning a final flourish as president of the UN COP28 summit by calling the heads of the world’s largest energy and tech companies for climate talks in Abu Dhabi days before COP29 begins...
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise it for post-traumatic...
...Joe Biden’s administration is planning to reclassify cannabis as a less harmful drug with a smaller legal penalty, in a historic shift for US drug policy, said people familiar with the matter....
...Bayer chief executive Bill Anderson has ruled out a fresh capital increase as he battles investor scepticism over his plan to turn around the indebted and litigation-stricken German drugs and pesticides...
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...Compared with all other consumer products — such as drugs and medical devices — Roundup has been the most targeted TV advertising since August, the firm said....
...Exclusivity on its two top-selling drugs will start to expire in two years, yet many of Bayer’s deals have been for early stage assets that will take time to produce results....
...These will be the first results from a study designed around landmark US Food and Drug Administration guidelines for researching psychedelics that were outlined last year, a decision that encouraged investors...
...The US Food and Drug Administration last year approved over-the-counter sales of Narcan — the branded version of naloxone, a nasal spray used to reverse opioid overdoses — in the hope that greater access...
...The abandoned asundexian trial “is a major setback for Bayer”, said Markus Manns, a portfolio manager and healthcare expert at Union Investment, Germany’s third-largest asset manager....
...Bayer shares plunged to lows not seen in the past decade after the drugmaker announced that a late-stage trial for a blood-thinning drug for heart disease had failed to show its efficacy....
...German drugs and crop science conglomerate Bayer has postponed a decision on whether to break itself up, as it launches a €2bn cost-cutting plan and promises to bring down debt....
...Bayer shocked investors this week when it halted a trial of its most promising new drug after discovering it did not work as well as planned....
...new drugs....
...Investors had long pushed Bayer to break itself into three separate groups, but Anderson said the expected loss of its exclusivity on key drugs, high debt, costly Roundup weedkiller litigation and the group...
...Just by way of example, the US Food and Drug Administration warned users to monitor Philips’ next generation DreamStation 2 for overheating last November....
...Designed to turn Bayer into a powerhouse in the global food industry, supplying farmers with everything from seeds to crop sprays, the deal instead saddled the German company with vast levels of debt and...
...Qatar’s prime minister, Sheikh Mohammed bin Abdulrahman al-Thani, said last month that the Gulf state was re-evaluating its role as a mediator in the conflict, lamenting that Doha’s efforts were being undermined...
...But in his low-key way, Jørgensen is pioneering a commercial innovation that could have a profound impact not just on healthcare, but on societies, on public finances and on our relationship with food....
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...“Big Pharma endorsing Amazon as a distribution partner bolsters Amazon’s role in healthcare and could be the start of many more of these arrangements.”...
...Meanwhile, Bayer reported a drop in annual sales and ebitda, with an expectation for further declines next year as it faces fresh competition for some of its best-selling drugs and lower prices for agriculture...
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
International Edition